What is the step‑by‑step treatment protocol for meningitis in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Step-by-Step Treatment of Meningitis in Children

Administer intravenous cefotaxime (75 mg/kg every 6-8 hours) or ceftriaxone (50 mg/kg every 12 hours, maximum 2g every 12 hours) plus vancomycin (10-15 mg/kg every 6 hours targeting trough 15-20 mg/mL) within 1 hour of presentation, along with dexamethasone (0.15 mg/kg every 6 hours) given with or before the first antibiotic dose. 1

Initial Assessment and Stabilization

Immediate Recognition

Look for the classic triad in older children:

  • Fever with headache and vomiting
  • Neck stiffness and photophobia
  • Altered mental status

In younger children and infants, presentation is often non-specific with fever, irritability, poor feeding, and bulging fontanelle.

Fluid Resuscitation (If Shock Present)

If signs of shock are present, immediately administer rapid intravenous fluid boluses:

  • Give isotonic crystalloid or colloid 20 ml/kg boluses
  • Reassess after each bolus
  • May require up to 60 ml/kg total (three 20 ml/kg boluses)
  • Fluid requirements often exceed 60 ml/kg plus inotropic support 2

Critical pitfall: Early consultation with intensive care is essential if repeated fluid boluses are needed, as inotropic and ventilatory support may be required 2.

Antibiotic Therapy

Age-Based Empirical Treatment

Children > 3 months:

  • Primary regimen: Cefotaxime 75 mg/kg every 6-8 hours PLUS vancomycin 10-15 mg/kg every 6 hours 1, 3
  • Alternative: Ceftriaxone 50 mg/kg every 12 hours (maximum 2g every 12 hours) PLUS vancomycin 1
  • Important caveat: Avoid ceftriaxone if calcium-containing parenteral solutions (IV calcium, parenteral nutrition, Hartmann's solution) were used in preceding 48 hours due to fatal interaction risk 2

Infants < 3 months:

  • Must add Listeria coverage: Cefotaxime PLUS ampicillin or amoxicillin (to cover Listeria and Group B Streptococcus) 2, 1

Duration of Antibiotic Therapy

  • Meningococcal meningitis: 7 days assuming satisfactory clinical progress 2
  • Pneumococcal meningitis: 10-14 days depending on susceptibility and clinical response 3
  • Listeria: 3 weeks with amoxicillin plus gentamicin or cotrimoxazole 3

Antibiotic Adjustment After Pathogen Identification

When pneumococcal MIC < 0.5 mg/L:

  • Continue third-generation cephalosporin alone for 10 days 3

When pneumococcal MIC ≥ 0.5 mg/L or resistant strain:

  • Continue cefotaxime/ceftriaxone PLUS vancomycin for 14 days
  • Consider adding rifampicin (10 mg/kg every 12 hours, maximum 600 mg/day) 1
  • Perform second lumbar puncture to assess response 3

When Neisseria meningitidis or Haemophilus influenzae identified:

  • Third-generation cephalosporin alone is sufficient 3

Adjunctive Dexamethasone Therapy

Dexamethasone 0.15 mg/kg every 6 hours for 4 days:

  • Start with or within 4 hours of first antibiotic dose (ideally simultaneously) 1
  • Continue for full 4 days in pneumococcal or H. influenzae meningitis 2, 1

Critical decision point for stopping dexamethasone:

  • Stop immediately if Listeria identified (associated with increased mortality) 1
  • For meningococcal meningitis, no clear harm or benefit—decision can be individualized but generally safe to continue 1
  • Do NOT use in meningococcal septicaemia (purpuric rash without clear meningitis) except in inotrope-resistant shock 2

Diagnostic Workup

Lumbar Puncture Timing

Perform lumbar puncture if no contraindications present:

Contraindications to immediate LP:

  • Coagulopathy or low platelets
  • Cardiovascular instability or shock
  • Signs of raised intracranial pressure (focal neurological signs, papilledema, altered consciousness)
  • Purpuric rash suggesting meningococcal septicaemia 2

Do NOT delay antibiotics for imaging or LP—start treatment within 1 hour of presentation 1, 4

CSF Analysis Must Include:

  • Opening pressure
  • Cell count with differential
  • Protein and glucose
  • Gram stain and culture
  • PCR testing for bacterial pathogens 1

Blood cultures must be obtained before antibiotics but should not delay treatment 4

Intensive Care Management

Indications for ICU Transfer

  • Continued deterioration despite appropriate supportive treatment 2
  • Fluid-resistant shock requiring inotropes 2
  • Need for ventilatory support 2

Advanced ICU Interventions

For inotrope-resistant shock:

  • Intravenous vasopressin
  • Steroid dose titration 2

For severe complications:

  • Consider continuous venovenous hemofiltration for inotrope-dependent septic shock with severe metabolic acidosis, acute renal failure, or complex fluid balance 2

Important note: ICP-based treatments (external drains, mannitol, methylprednisolone) are NOT recommended for routine care until RCTs demonstrate benefit, as they are potentially harmful 1

Prevention of Secondary Transmission

Immediately liaise with public health for meningococcal disease:

  • Offer chemoprophylaxis (ciprofloxacin, rifampicin, or minocycline) to close contacts
  • Close contacts defined as: household members, dormitory roommates, boyfriends/girlfriends, those sharing kitchen facilities 2
  • Prophylaxis indicated for contact within 7 days before illness onset 2

Follow-Up Care

All survivors require:

  • Audiological examination (hearing loss occurs in 30-54% of survivors even without clinically apparent deficits) 1
  • Neuropsychological assessment (cognitive deficits occur in 32% of survivors) 1
  • Pneumococcal vaccination to prevent recurrence 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.